FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117433422> ?p ?o ?g. }

• W2117433422 endingPage "469" @default.
• W2117433422 startingPage "463" @default.
• W2117433422 abstract "Objective High serum interferon α (IFNα) activity is a heritable risk factor for systemic lupus erythematosus (SLE). Auto-antibodies found in SLE form immune complexes which can stimulate IFNα production by activating endosomal Toll-like receptors and interferon regulatory factors (IRFs), including IRF5. Genetic variation in IRF5 is associated with SLE susceptibility; however, it is unclear how IRF5 functional genetic elements contribute to human disease. Methods 1034 patients with SLE and 989 controls of European ancestry, 555 patients with SLE and 679 controls of African–American ancestry, and 73 patients with SLE of South African ancestry were genotyped at IRF5 polymorphisms, which define major haplotypes. Serum IFNα activity was measured using a functional assay. Results In European ancestry subjects, anti-double-stranded DNA (dsDNA) and anti-Ro antibodies were each associated with different haplotypes characterised by a different combination of functional genetic elements (OR>2.56, p<1.9×10 −14 for both). These IRF5 haplotype-auto-antibody associations strongly predicted higher serum IFNα in patients with SLE and explained >70% of the genetic risk of SLE due to IRF5. In African–American patients with SLE a similar relationship between serology and IFNα was observed, although the previously described European ancestry-risk haplotype was present at admixture proportions in African–American subjects and absent in African patients with SLE. Conclusions The authors define a novel risk haplotype of IRF5 that is associated with anti-dsDNA antibodies and show that risk of SLE due to IRF5 genotype is largely dependent upon particular auto-antibodies. This suggests that auto-antibodies are directly pathogenic in human SLE, resulting in increased IFNα in cooperation with particular combinations of IRF5 functional genetic elements. SLE is a systemic autoimmune disorder affecting multiple organ systems including the skin, musculoskeletal, renal and haematopoietic systems. Humoral autoimmunity is a hallmark of SLE, and patients frequently have circulating auto-antibodies directed against dsDNA, as well as RNA binding proteins (RBP). Anti-RBP autoantibodies include antibodies which recognize Ro, La, Smith (anti-Sm), and ribonucleoprotein (anti-nRNP), collectively referred to as anti-retinol-binding protein). Anti-retinol-binding protein and anti-dsDNA auto-antibodies are rare in the healthy population.1 These auto-antibodies can be present in sera for years preceding the onset of clinical SLE illness2 and are likely pathogenic in SLE.3 4" @default.
• W2117433422 created "2016-06-24" @default.
• W2117433422 creator A5000535517 @default.
• W2117433422 creator A5007576322 @default.
• W2117433422 creator A5007698654 @default.
• W2117433422 creator A5010072602 @default.
• W2117433422 creator A5011480199 @default.
• W2117433422 creator A5014962817 @default.
• W2117433422 creator A5015771262 @default.
• W2117433422 creator A5024269575 @default.
• W2117433422 creator A5025774056 @default.
• W2117433422 creator A5033739232 @default.
• W2117433422 creator A5036124130 @default.
• W2117433422 creator A5041270389 @default.
• W2117433422 creator A5047746252 @default.
• W2117433422 creator A5052053321 @default.
• W2117433422 creator A5052973247 @default.
• W2117433422 creator A5056255167 @default.
• W2117433422 creator A5061226924 @default.
• W2117433422 creator A5062742878 @default.
• W2117433422 creator A5066883334 @default.
• W2117433422 creator A5081462483 @default.
• W2117433422 creator A5082713013 @default.
• W2117433422 creator A5082825997 @default.
• W2117433422 creator A5085769049 @default.
• W2117433422 creator A5086055060 @default.
• W2117433422 creator A5086308019 @default.
• W2117433422 creator A5088161589 @default.
• W2117433422 creator A5088206527 @default.
• W2117433422 creator A5088258614 @default.
• W2117433422 date "2011-11-16" @default.
• W2117433422 modified "2023-10-16" @default.
• W2117433422 title "IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus" @default.
• W2117433422 cites W1848507162 @default.
• W2117433422 cites W1900316083 @default.
• W2117433422 cites W1964982194 @default.
• W2117433422 cites W1965672602 @default.
• W2117433422 cites W1968623559 @default.
• W2117433422 cites W1973431560 @default.
• W2117433422 cites W1978231377 @default.
• W2117433422 cites W1981586273 @default.
• W2117433422 cites W2005375258 @default.
• W2117433422 cites W2011330612 @default.
• W2117433422 cites W2014008318 @default.
• W2117433422 cites W2016758677 @default.
• W2117433422 cites W2021109112 @default.
• W2117433422 cites W2026255377 @default.
• W2117433422 cites W2028825739 @default.
• W2117433422 cites W2035242178 @default.
• W2117433422 cites W2037487383 @default.
• W2117433422 cites W2048537061 @default.
• W2117433422 cites W2050462079 @default.
• W2117433422 cites W2065907531 @default.
• W2117433422 cites W2078610240 @default.
• W2117433422 cites W2085013699 @default.
• W2117433422 cites W2100068629 @default.
• W2117433422 cites W2100516310 @default.
• W2117433422 cites W2102975150 @default.
• W2117433422 cites W2103532849 @default.
• W2117433422 cites W2103707875 @default.
• W2117433422 cites W2145978988 @default.
• W2117433422 cites W2146203649 @default.
• W2117433422 cites W2146669607 @default.
• W2117433422 cites W2149346425 @default.
• W2117433422 cites W2318971911 @default.
• W2117433422 cites W2434492847 @default.
• W2117433422 cites W2462644910 @default.
• W2117433422 doi "https://doi.org/10.1136/annrheumdis-2011-200463" @default.
• W2117433422 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3307526" @default.
• W2117433422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22088620" @default.
• W2117433422 hasPublicationYear "2011" @default.
• W2117433422 type Work @default.
• W2117433422 sameAs 2117433422 @default.
• W2117433422 citedByCount "125" @default.
• W2117433422 countsByYear W21174334222012 @default.
• W2117433422 countsByYear W21174334222013 @default.
• W2117433422 countsByYear W21174334222014 @default.
• W2117433422 countsByYear W21174334222015 @default.
• W2117433422 countsByYear W21174334222016 @default.
• W2117433422 countsByYear W21174334222017 @default.
• W2117433422 countsByYear W21174334222018 @default.
• W2117433422 countsByYear W21174334222019 @default.
• W2117433422 countsByYear W21174334222020 @default.
• W2117433422 countsByYear W21174334222021 @default.
• W2117433422 countsByYear W21174334222022 @default.
• W2117433422 countsByYear W21174334222023 @default.
• W2117433422 crossrefType "journal-article" @default.
• W2117433422 hasAuthorship W2117433422A5000535517 @default.
• W2117433422 hasAuthorship W2117433422A5007576322 @default.
• W2117433422 hasAuthorship W2117433422A5007698654 @default.
• W2117433422 hasAuthorship W2117433422A5010072602 @default.
• W2117433422 hasAuthorship W2117433422A5011480199 @default.
• W2117433422 hasAuthorship W2117433422A5014962817 @default.
• W2117433422 hasAuthorship W2117433422A5015771262 @default.
• W2117433422 hasAuthorship W2117433422A5024269575 @default.
• W2117433422 hasAuthorship W2117433422A5025774056 @default.
• W2117433422 hasAuthorship W2117433422A5033739232 @default.
• W2117433422 hasAuthorship W2117433422A5036124130 @default.

• next